PARD — Poniard Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Poniard Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2006 December 31st	2007 December 31st	C2008 December 31st	2009 December 31st	2010 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	53.7	92.6	72.8	43.4	4.33
Prepaid Expenses
Total Other Current Assets
Total Current Assets	54.5	93.9	74	44.5	5.22
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.525	1.12	1.12	0.219	0.049
Net Intangible Assets
Other Long Term Assets
Total Assets	69.1	105	84.2	52.4	11.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	12.2	9.47	19.1	17.1	1.62
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	22.2	16	36.6	28.8	3.19
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	46.9	89.1	47.6	23.6	8.45
Total Liabilities & Shareholders' Equity	69.1	105	84.2	52.4	11.6
Total Common Shares Outstanding
Total Preferred Shares Outstanding